Insomnia due to medical condition
Methodology & AI Transparency ⓘ
Insomnia due to medical condition Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Recognized across U.S.
- 2 Real-world patient consensus: Diagnostic registry G47.01: Insomnia due to medical condition is managed within Sleep Disorders.
- 3 Typical cash cost range: Primary evaluation for Insomnia due to medical condition incorporates home sleep apnea in Insomnia due to medical condition (G47.01: testing (HSAT) or) and symptom diary review.
- 4 Top reported side effects / signs: Objective lab/clinical target for Insomnia due to medical condition: Insomnia Severity Index in Insomnia due to medical condition (G47.01: (ISI)) (< 7 (G47.01)) and Nocturnal Oxygen Saturation in Insomnia due to medical condition (G47.01: (SpO2)).
Ask our AI Specialists anything about Insomnia due to medical condition
What Is Insomnia due to medical condition?
Recognized across U.S. clinical coding as G47.01 (Sleep Disorders), Insomnia due to medical condition is evaluated via home sleep apnea in Insomnia due to medical condition (G47.01: testing (HSAT) or) to align day-to-day symptom relief with long-term physiological stability.
Pathophysiology, Underlying Causes & Clinical Presentation
At the cellular and tissue level in sleep disorders, Insomnia due to medical condition (G47.01) involves intermittent nocturnal hypoxia [Insomnia due to medical condition G47.01]. progression correlates with shifts in Insomnia Severity Index in Insomnia due to medical condition (G47.01: (ISI)) (< 7 (G47.01)).
Common Symptoms & Clinical Signs
- • Presentation of Insomnia due to medical condition (G47.01): unrefreshing morning waking in Insomnia due to medical condition (G47.01: despite adequate hours)
- • Secondary Insomnia due to medical condition clinical sign: loud habitual snoring, in Insomnia due to medical condition (G47.01: witnessed breathing pauses,)
- • Symptom flares in Insomnia due to medical condition correlating with Insomnia Severity Index in Insomnia due to medical condition (G47.01: (ISI)) deviation outside < 7 (G47.01)
- • Functional sleep disorders impact requiring home sleep apnea in Insomnia due to medical condition (G47.01: testing (HSAT) or) evaluation (G47.01)
Insomnia due to medical condition Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | G47.01 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Insomnia, Sleep Apnea & Sleep Health | NLM Clinical Tables |
| Diagnostic / Lab Marker: Insomnia Severity Index in Insomnia due to medical condition (G47.01: (ISI)) | < 7 (G47.01) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Nocturnal Oxygen Saturation in Insomnia due to medical condition (G47.01: (SpO2)) | >= 94% nadir > 90% (G47.01) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Serum Ferritin (Restless in Insomnia due to medical condition (G47.01: Legs)) | > 75 ng/mL (G47.01) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Insomnia due to medical condition
Treatment selection for Insomnia due to medical condition depends on clinical severity, diagnostic lab results, and medical history. Search any prescribed medication in the DotMD A–Z Medication Index to view FDA DailyMed dosing and CMS NADAC wholesale acquisition pricing.
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Insomnia due to medical condition)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| New Insights on Re-examining the factor structure of the trouble sleeping Severity Index (ISI): What a 1,956-Participant Study Found A 6-item two-factor scale had better psychometric properties than the 7-item scale in this patient sample. Journal of patient-reported outcomes • 2024-06-29 • Phase III Randomized Trial | N = 1,956 | 96/100 | PMID 38951287 ↗ |
| New Insights on Interventions for trouble sleeping in cancer patients and survivors-a: What a 6,528-Participant Study Found CBT-I is supported as a first-line treatment for trouble sleeping in cancer survivors, with significant benefits observed across sleep and non-sleep outcomes. JNCI cancer spectrum • 2024-04-30 • Meta-Analysis | N = 6,528 | 94/100 | PMID 38781520 ↗ |
| New Insights on Acute efficacy of fluoxetine versus sertraline and paroxetine in depression: What a 284-Participant Study Found These data show no significant differences in acute treatment efficacy and tolerability across fluoxetine, sertraline, and paroxetine in depression patients. Journal of clinical psychopharmacology • 2002-04-15 • Randomized Controlled Trial | N = 284 | 93/100 | PMID 11910258 ↗ |
| New Insights on Long-term effectiveness and safety of lemborexant in adults with trouble sleeping: What a 949-Participant Study Found LEM5 and LEM10 had significant benefit on sleep onset and sleep maintenance compared with placebo, and importantly, lemborexant effectiveness persisted at twelve months, suggesting that lemborexant may provide long-term... Sleep medicine • 2021-04-15 • Phase III Randomized Trial | N = 949 | 93/100 | PMID 33636648 ↗ |
| New Insights on Meaningful Within-Patient Change on the trouble sleeping Daytime Symptoms and: What a 930-Participant Study Found This analysis demonstrates the meaningful within-patient change for the IDSIQ total score and domain scores, that the instrument is sensitive to changes in the patient experience of trouble sleeping, and that it can be used in... Pharmaceutical medicine • 2023-07-15 • Phase III Randomized Trial | N = 930 | 93/100 | PMID 37286927 ↗ |
Insomnia due to medical condition Patient Community & “People Like Me” Threads
Filter Insomnia due to medical condition community threads and patient logs by age, biological sex, dosage, and treatment duration.